Literature DB >> 19477207

Myxoma virus M130R is a novel virulence factor required for lethal myxomatosis in rabbits.

John W Barrett1, Steven J Werden, Fuan Wang, William M McKillop, June Jimenez, Danielle Villeneuve, Grant McFadden, Gregory A Dekaban.   

Abstract

Myxoma virus (MV) is a highly lethal, rabbit-specific poxvirus that induces a disease called myxomatosis in European rabbits. In an effort to understand the function of predicted immunomodulatory genes we have deleted various viral genes from MV and tested the ability of these knockout viruses to induce lethal myxomatosis. MV encodes a unique 15 kD cytoplasmic protein (M130R) that is expressed late (12h post infection) during infection. M130R is a non-essential gene for MV replication in rabbit, monkey or human cell lines. Construction of a targeted gene knockout virus (vMyx130KO) and infection of susceptible rabbits demonstrate that the M130R knockout virus is attenuated and that loss of M130R expression allows the rabbit host immune system to effectively respond to and control the lethal effects of MV. M130R expression is a bona fide poxviral virulence factor necessary for full and lethal development of myxomatosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477207     DOI: 10.1016/j.virusres.2009.05.009

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.

Authors:  Rohann J M Correa; Monica Komar; Jessica G K Tong; Milani Sivapragasam; Masmudur M Rahman; Grant McFadden; Gabriel E Dimattia; Trevor G Shepherd
Journal:  Gynecol Oncol       Date:  2012-02-01       Impact factor: 5.482

2.  Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.

Authors:  Chen Peng; Sherry L Haller; Masmudur M Rahman; Grant McFadden; Stefan Rothenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

Review 3.  The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics.

Authors:  Jia Liu; Sonia Wennier; Grant McFadden
Journal:  Microbes Infect       Date:  2010-09-09       Impact factor: 2.700

4.  Molecular characterisation of virulence graded field isolates of myxoma virus.

Authors:  Kevin P Dalton; Ines Nicieza; Aroa Baragaño; Jose Manuel Martín Alonso; Francisco Parra
Journal:  Virol J       Date:  2010-02-26       Impact factor: 4.099

5.  Myxoma Virus M083 Is a Virulence Factor Which Mediates Systemic Dissemination.

Authors:  A M Wolfe; K M Dunlap; A C Smith; M Y Bartee; E Bartee
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 6.  The current status and future directions of myxoma virus, a master in immune evasion.

Authors:  Bart Spiesschaert; Grant McFadden; Katleen Hermans; Hans Nauwynck; Gerlinde R Van de Walle
Journal:  Vet Res       Date:  2011-06-09       Impact factor: 3.683

Review 7.  Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.

Authors:  Peter J Kerr; June Liu; Isabella Cattadori; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  Viruses       Date:  2015-03-06       Impact factor: 5.048

8.  Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.

Authors:  Peter J Kerr; Isabella M Cattadori; Matthew B Rogers; Adam Fitch; Adam Geber; June Liu; Derek G Sim; Brian Boag; John-Sebastian Eden; Elodie Ghedin; Andrew F Read; Edward C Holmes
Journal:  PLoS Pathog       Date:  2017-03-02       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.